Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures.

{"article_title":"Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures.","author":"Elmets CA, Korman NJ, Prater EF, Wong EB, Rupani RN, Kivelevitch D, Armstrong AW, Connor C, Cordoro KM, Davis DMR, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kroshinsky D, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Paller AS, Parra SL, Pathy AL, Siegel M, Stoff B, Strober B, Wu JJ, Hariharan V, Menter A","journal_title":"Journal of the American Academy of Dermatology","issn":"1097-6787","isbn":"","publication_date":"2021-02-01","volume":"84","issue":"2","first_page":"432","page_count":"","accession_number":"32738429","doi":"10.1016\/j.jaad.2020.07.087","publisher":"Mosby","doctype":"Journal Article","subjects":"United States; Complementary Therapies methods; Dermatologic Agents administration & dosage; Dermatology methods; Psoriasis therapy; Academies and Institutes standards; Administration, Cutaneous; Combined Modality Therapy methods; Combined Modality Therapy standards; Complementary Therapies standards; Dermatology standards; Evidence-Based Medicine methods; Evidence-Based Medicine standards; Foundations standards; Humans; Patient Education as Topic standards; Psoriasis diagnosis; Severity of Illness Index; Treatment Outcome; United States","interest_area":["Dermatology"],"abstract":"Psoriasis is a chronic, inflammatory, multisystem disease that affects up to 3.2% of the United States population. This guideline addresses important clinical questions that arise in psoriasis management and care and provides recommendations based on the available evidence. The treatment of psoriasis with topical agents and with alternative medicine will be reviewed, emphasizing treatment recommendations and the role of dermatologists in monitoring and educating patients regarding benefits as well as risks that may be associated. This guideline will also address the severity assessment methods of psoriasis in adults. Copyright \u00a9 2020 American Academy of Dermatology, Inc. All rights reserved.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=32738429","isPdfLink":false,"isSAML":false,"an":"32738429","number_other":"","type_pub":"","issn_electronic":"1097-6787","languages":"English","language":"eng","date_entry":"Date Created: 20200802 Date Completed: 20210729 Latest Revision: 20210729","date_update":"20240104","titleSource":"Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2021 Feb; Vol. 84 (2), pp. 432-470. Date of Electronic Publication: 2020 Jul 30.","date_pub_cy":"","type_document":"","contract_publisher":"","authored_on":"2021-02-01","description":"Psoriasis is a chronic, inflammatory, multisystem disease that affects up to 3.2% of the United States population. This guideline addresses important clinical questions that arise in psoriasis management and care and provides recommendations based on the available evidence. The treatment of psoriasis with topical agents and with alternative medicine will be reviewed, emphasizing treatment recommendations and the role of dermatologists in monitoring and educating patients regarding benefits as well as risks that may be associated. This guideline will also address the severity assessment methods of psoriasis in adults.<br \/> (Copyright © 2020 American Academy of Dermatology, Inc. All rights reserved.)","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&scope=site&db=mdl&AN=32738429&authtype=shib&custid=ns346513&group=main&profile=eds","no_of_pages":"","authored_by":"Elmets CA, Korman NJ, Prater EF, Wong EB, Rupani RN, Kivelevitch D, Armstrong AW, Connor C, Cordoro KM, Davis DMR, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kroshinsky D, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Paller AS, Parra SL, Pathy AL, Siegel M, Stoff B, Strober B, Wu JJ, Hariharan V, Menter A"}